Welcome to our dedicated page for Regency Centers SEC filings (Ticker: REGCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Regency Centers's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Regency Centers's regulatory disclosures and financial reporting.
A security holder filed a Form 144/A notice to potentially sell 15,000 shares of common stock, with an aggregate market value of $1,135,800. The proposed sale, through Charles Schwab Corp on NASDAQ, is targeted for around 02/09/2026.
These 15,000 shares were acquired on 02/10/2023 directly from the issuer as equity compensation, rather than a cash purchase. Shares outstanding were reported at 182,900,978; this is a baseline figure, not the planned sale amount. No sales over the past three months are listed for this holder.
Regency Centers Corp officer Devereaux Terah L, the Principal Accounting Officer, reported several equity-related transactions on February 12, 2026. The filing shows the exercise or conversion of derivative awards into 3,506 shares of Common Stock, partly linked to restricted stock vesting and dividend equivalents.
The report also shows a tax-withholding disposition of 1,479 shares of Common Stock at $73.40 to cover obligations tied to these awards. After these transactions, Devereaux Terah L directly owned 19,230 shares of Common Stock and 8,051 shares of Restricted Stock.
Regency Centers Corporation Senior VP and General Counsel Michael R. Herman reported equity award activity on February 12, 2026. He acquired 7,459 shares of common stock through the vesting and conversion of restricted stock and related dividend equivalents.
To cover tax obligations, 2,807 common shares were disposed of at $73.40 per share, leaving him with 21,601 common shares held directly and 4,257 shares of restricted stock. The company notes that a prior report understated his restricted stock grant by 538 shares, now correctly reflected as of February 17, 2026.
STEIN MARTIN E JR reported multiple insider transaction types in a Form 4 filing for REG. The filing lists transactions totaling 36,566 shares at a weighted average price of $73.40 per share. Following the reported transactions, holdings were 10,081 shares.
Regency Centers Corp President and CEO Lisa Palmer reported equity award activity. On February 12, 2026, she acquired 82,877 shares of common stock through the vesting and conversion of performance shares, restricted stock, and related dividend equivalents. On the same date, she disposed of 32,625 shares at $73.40 per share to satisfy tax withholding obligations. After these transactions, she directly owned 157,942 shares of common stock.
Regency Centers Corporation officer Nicholas Andrew Wibbenmeyer exercised stock awards and had shares withheld to cover taxes. On 02/12/2026 he acquired 17,345 shares of common stock through the conversion of 15,402 restricted stock units and 1,943 dividend equivalents. In a related tax-withholding transaction, 9,418 shares of common stock were disposed of at $73.40 per share. After these transactions, he directly owned 40,995.55 shares of Regency Centers common stock.
ROTH ALAN TODD reported multiple insider transaction types in a Form 4 filing for REG. The filing lists transactions totaling 41,594 shares at a weighted average price of $73.40 per share. Following the reported transactions, holdings were 30,203 shares.
Regency Centers Corp EVP and CFO Michael J. Mas reported equity award activity involving company stock. On February 12, 2026, he acquired 26,196 shares of common stock through the vesting and conversion of restricted stock and performance-based awards, including dividend-equivalent shares. To cover tax obligations, 10,367 common shares were disposed of at $73.40 per share through share withholding. After these transactions, he directly owned 54,849 shares of common stock and 37,001 derivative securities tied to restricted stock awards.
T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting a passive ownership stake in Regency Centers Corp. As of December 31, 2025, it reported beneficial ownership of 8,873,400 shares, representing 4.9% of the class.
The firm reported sole voting power over 8,785,218 shares and sole dispositive power over 8,873,384 shares, with no shared voting or dispositive power. It certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Regency Centers. The filing also expressly denies that T. Rowe Price Associates is the beneficial owner of the securities in a broader legal sense.
Regency Centers Corp officer Alan Todd Roth, Eastern Regional President and COO, reported selling 8,000 shares of common stock on February 10, 2026. The weighted average sale price was $77.05 per share, with individual trades ranging from $77.01 to $77.12.
After this transaction, Roth directly beneficially owns 14,991 shares of Regency Centers common stock. The sale was executed in multiple market transactions, and detailed price breakdowns are available upon request to the company or the SEC staff.